HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,077,741 | +6.3% | 13,703 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $1,014,000 | +13.5% | 13,703 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $893,000 | +3.1% | 13,703 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $866,000 | +19.1% | 13,703 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $727,000 | -24.8% | 13,703 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $967,000 | +41.2% | 13,703 | +33.3% | 0.00% | 0.0% |
| Q2 2021 | $685,000 | -73.4% | 10,277 | -55.7% | 0.00% | -75.0% |
| Q1 2021 | $2,575,000 | +781.8% | 23,200 | +212.9% | 0.01% | 0.0% |
| Q2 2017 | $292,000 | – | 7,414 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |